ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Business/CompaniesArticle

Abbott debuts first sterile, ready-to-feed whole milk infant formula in U.S.

Similac 360 Total Care Made With Whole Milk launches as the first commercially sterile liquid infant formula using whole milk, priced competitively with powdered alternatives. Target and Amazon begin sales Monday, with Walmart expansion planned.

HV
Helena Vásquez · Business Desk · 31 Aug 2026 · 15:11 · 1 min read
Share
Abbott debuts first sterile, ready-to-feed whole milk infant formula in U.S.

Abbott Laboratories introduced Similac 360 Total Care Made With Whole Milk, the first commercially sterile, ready-to-feed liquid infant formula made with whole milk available in the United States. The product launched Monday, following regulatory guidance emphasizing the use of commercially sterile liquid formulas for infants under two months or those with compromised immune systems when breast milk is unavailable.

The new formula combines whole milk with five human milk oligosaccharides, designed to support digestive health. Abbott states the product is non-GMO and excludes artificial growth hormones, corn syrup, and palm olein oil. Each batch is manufactured at the company’s U.S. production facility, ensuring commercial sterility through heat treatment to eliminate spores of harmful microorganisms such as Clostridium.

Pricing aligns with Abbott’s existing Similac 360 Total Care powdered formulas on a per-feeding basis. The product is available in 8 fluid ounce and 32 fluid ounce ready-to-feed formats, with Target and Amazon beginning sales Monday. Walmart and additional retail locations are expected to carry the formula in the coming weeks.

Abbott’s original Similac 360 Total Care liquid infant formula will continue to be sold in 2 fluid ounce and 8 fluid ounce ready-to-feed formats, while powdered versions remain available across multiple sizes and price points. The company did not disclose specific sales projections or market share targets for the new product.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
HV
Written by
Helena Vásquez
Business Desk

Helena covers corporate news for listed and private companies across Europe, from strategy shifts to leadership changes, with an eye for what a story signals about the broader market.

More from Helena Vásquez →
ADVERTISEMENT
ADVERTISEMENT